MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Stephen Farber
  • Male
  • New York, NY
  • United States
Share on Facebook Share on Facebook Share
  • Blog Posts
  • Upcoming Events
  • MedTechIQ Groups (3)
  • MedTech-IQ ... At a Glance
  • Photo Albums
  • MedTechIQ VideoLibrary

Stephen Farber's Contacts

  • CC-Conrad Clyburn-MedForeSight

Gifts Received


Stephen Farber has not received any gifts yet

Give a Gift


Stephen Farber's Page

Latest Activity

Stephen Farber was featured
Jun 18, 2010
Stephen Farber was featured
May 6, 2010
Stephen Farber updated their profile
May 5, 2010
Stephen Farber joined CC-Conrad Clyburn-MedForeSight's group

CEOs, Angels, VCs & T2 Experts/Stimulus Funding

An affiliation group of those who are interested in investing in emerging medical technology or seeking funding to advance the commercialization of new medical technology.
May 5, 2010
Stephen Farber joined CC-Conrad Clyburn-MedForeSight's group

Advanced Medical Imaging

An affiliation group dedicated to advancing the horizons of multi-modality imaging, multi-center image management, molecular imaging and new applications for broad band image management.
Jul 27, 2009
Stephen Farber joined CC-Conrad Clyburn-MedForeSight's group

Telemedicine & eHealth

An affiliation group dedicated to advancing the use of telemedicine to improve the quality of care, enhance access to care and decrease the cost of healthcare delivery.
Jul 27, 2009
Stephen Farber is now a member of MedTech I.Q.
Jul 27, 2009

Profile Information

Area of Expertise or Interest?
Web-based PACS. Law. Investment Banking.
Type of Affiliation?

A little about my current business endeavor

I am CEO (and a principal owner) of UltraLinq, a NY and Raleigh-based company. UltraLinq is a disruptive web-based service which cost-effectively allows for the transmission, review, reporting, QA/QC management, distribution and archiving of ultrasound studies, addressing a desperate need in the market.

With early success, we are now looking to quickly accelerate the growth of UltraLinq to establish market leadership in several large niche markets within medical study management. Our service is delivered under a SaaS model.

UltraLinq was a vendor of mine prior to November 2007, when I concluded that UltraLinq had the opportunity to change the management of medical studies throughout much of the healthcare system. Along with my partners, we invested in the Company, and are now looking to accelerate growth throughout the US and abroad. I am interested in speaking/meeting with people who have similar business interests, and are interested in helping us to grow our company through a broad range of distribution channels and development strategies.

Comment Wall

You need to be a member of MedTech I.Q. to add comments!

Join MedTech I.Q.

  • No comments yet!

© 2017   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service